CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 211 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $535,825 | +2.3% | 16,492 | -20.7% | 0.00% | 0.0% |
Q1 2024 | $523,700 | -22.3% | 20,790 | +0.2% | 0.00% | -33.3% |
Q4 2023 | $674,155 | +80.4% | 20,756 | +51.3% | 0.00% | +50.0% |
Q3 2023 | $373,747 | +22.4% | 13,718 | 0.0% | 0.00% | +100.0% |
Q2 2023 | $305,226 | +2.7% | 13,718 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $297,132 | +27.7% | 13,718 | +19.8% | 0.00% | 0.0% |
Q4 2022 | $232,651 | -30.1% | 11,455 | -11.7% | 0.00% | -50.0% |
Q3 2022 | $333,000 | +7.8% | 12,977 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $309,000 | -11.0% | 12,977 | -15.8% | 0.00% | 0.0% |
Q1 2022 | $347,000 | +13.8% | 15,416 | 0.0% | 0.00% | +100.0% |
Q4 2021 | $305,000 | +25.5% | 15,416 | +25.0% | 0.00% | 0.0% |
Q3 2021 | $243,000 | -10.3% | 12,334 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $271,000 | -7.5% | 12,334 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $293,000 | -28.2% | 12,334 | -20.8% | 0.00% | 0.0% |
Q4 2020 | $408,000 | +50.6% | 15,582 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $271,000 | +3.4% | 15,582 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $262,000 | +178.7% | 15,582 | +98.1% | 0.00% | +100.0% |
Q1 2020 | $94,000 | +28.8% | 7,864 | +30.7% | 0.00% | 0.0% |
Q4 2019 | $73,000 | -14.1% | 6,015 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $85,000 | +26.9% | 6,015 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $67,000 | -5.6% | 6,015 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $71,000 | -9.0% | 6,015 | +2.6% | 0.00% | 0.0% |
Q4 2018 | $78,000 | -4.9% | 5,862 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $82,000 | +1.2% | 5,862 | +13.1% | 0.00% | 0.0% |
Q2 2018 | $81,000 | -4.7% | 5,183 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $85,000 | -9.6% | 5,183 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $94,000 | +70.9% | 5,183 | +80.4% | 0.00% | 0.0% |
Q3 2017 | $55,000 | +61.8% | 2,873 | 0.0% | 0.00% | – |
Q2 2017 | $34,000 | +9.7% | 2,873 | 0.0% | 0.00% | – |
Q1 2017 | $31,000 | +47.6% | 2,873 | 0.0% | 0.00% | – |
Q4 2016 | $21,000 | +40.0% | 2,873 | +23.9% | 0.00% | – |
Q3 2016 | $15,000 | +15.4% | 2,319 | 0.0% | 0.00% | – |
Q2 2016 | $13,000 | +18.2% | 2,319 | 0.0% | 0.00% | – |
Q1 2016 | $11,000 | -8.3% | 2,319 | 0.0% | 0.00% | – |
Q4 2015 | $12,000 | +33.3% | 2,319 | 0.0% | 0.00% | – |
Q3 2015 | $9,000 | – | 2,319 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,372,001 | $98,287,000 | 4.68% |
TANAKA CAPITAL MANAGEMENT INC | 79,574 | $934,000 | 2.82% |
Consonance Capital Management LP | 3,747,453 | $43,995,000 | 2.78% |
S&T BANK/PA | 613,740 | $7,205,000 | 1.62% |
AJ WEALTH STRATEGIES, LLC | 595,834 | $6,995,000 | 1.16% |
Capital Impact Advisors, LLC | 193,694 | $2,522,000 | 1.12% |
TEALWOOD ASSET MANAGEMENT INC | 154,615 | $1,815,000 | 0.77% |
AMI ASSET MANAGEMENT CORP | 722,932 | $8,487,000 | 0.63% |
Birchview Capital, LP | 50,000 | $587,000 | 0.37% |
FEDERATED HERMES, INC. | 11,176,281 | $131,210,000 | 0.32% |